Bristol Myers Squibb (BMY)

Deferred Revenue

$0.00

Quarterly · Period ending: · USD

BMY logo

BMY Deferred Revenue

Latest reported$0.00
BMY Quarterly Deferred Revenue ($0.00 → $0.00)
High-resolution chart · PNG

BMY deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86,000,000
92,000,000
103,000,000
172,000,000
93,000,000
88,000,000
117,000,000
83,000,000
647,000,000
737,000,000
837,000,000
762,000,000
1,323,000,000
1,182,000,000
1,165,000,000
1,003,000,000
963,000,000
939,000,000
1,459,000,000
1,167,000,000
995,000,000
1,090,000,000
1,061,000,000
756,000,000
1,003,000,000
986,000,000
772,000,000
825,000,000
689,000,000
357,000,000
287,000,000
337,000,000
321,000,000
283,000,000
347,000,000
402,000,000
289,000,000
275,000,000
265,000,000
237,000,000
276,000,000
267,000,000
321,000,000
277,000,000
832,000,000
742,000,000
616,000,000
447,000,000
427,000,000
443,000,000
387,000,000
411,000,000
0
0
0
125,000,000
0
0
11,000,000
32,000,000
37,000,000
48,000,000
49,000,000
76,000,000
83,000,000
110,000,000
174,000,000
470,000,000
1,157,000,000
0
0
2,026,000,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.